Creating a safe CAR T-Cell therapy to fight solid tumors in children

Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors including childhood cancers such as neuroblastoma. Preclinical studies using certain CAR T against neuroblastoma revealed toxic effects. Now, a group of scientists at Children’s Hospital Los Angeles have developed a modified version of CAR T…

The Benefits of Moderate Exercise

The other men began a typical moderate-exercise program, riding bikes at the lab five times a week at a pace they could comfortably sustain for 30 to 40 minutes. Over the course of the next six weeks, the HIIT group pedaled intensely for a grand total of less than an hour, while the moderate-intensity group…

New Parkinson’s disease therapeutics discovered by Ben-Gurion U researchers

BEER-SHEVA, Israel…January 20, 2021 -Ben-Gurion University of the Negev researchers have discovered that the protein BMP5/7 offers promising therapeutics that could slow down or halt the progression of Parkinson’s disease. The findings were published in the prestigious clinical neurology journal, Brain. Parkinson’s disease, which affects over one million people in U.S. and 10 million worldwide,…